Letter

Tracking system for studies should be in place

BMJ 2004; 329 doi: 10.1136/bmj.329.7458.173-b (Published 15 July 2004)
Cite this as: BMJ 2004;329:173.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. J A C Delaney (chris.delaney@clinepi.mcgill.ca), statistician, clinical epidemiology
  1. Royal Victoria Hospital, R 4.36, 687 Pine Avenue W, Montreal, QC, Canada H3A 1A1

    EDITOR—GlaxoSmithKline's recent legal troubles resulting from not publishing negative results of clinical trials on the antidepressant paroxetine are just part of a larger problem of publication bias in modern research.1

    There has been …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular